Insight

New in Cardio-Oncology: VMAT shows no early cardiac function decline for left-sided breast cancer patients

Photo taken from tendna.com

Jul 25, 2024, 21:47

New in Cardio-Oncology: VMAT shows no early cardiac function decline for left-sided breast cancer patients

Memorial Sloan Kettering Radiation Oncology shared on X:

“New in Cardio-Oncology breast cancer, Lior Braunstein:

VMAT for left-sided breast cancer RNI yielded no significant early decrement in echocardiographic parameters of cardiac function.

No patient exhibited significant LVEF changes or sustained decrements in strain.”

Source: Memorial Sloan Kettering Radiation Oncology/X

Echocardiographic functional outcomes following regional nodal irradiation for breast cancer using volumetric modulated arc therapy.

Authors: Anthony F. Yu, Charlie White, Zhigang Zhang, Jennifer E. Liu, Erin F Gillespie, Beryl McCormick, Atif J Khan, Richard M. Steingart, Simon N Powell, Oren Cahlon, Lior Z. Braunstein.

cardiac

Anthony F. Yu Atif J Khan Beryl McCormick Breast Cancer breast cancer patients cancer cardiac function Cardio-Oncology Charlie White Erin F Gillespie Jennifer E. Liu left-sided breast cancer Lior Braunstein Lior Z. Braunstein LVEF changes Memorial Sloan Kettering Radiation Oncology OncoDaily Oncology Oren Cahlon Richard M. Steingart Simon N. Powell VMAT Zhigang Zhang

Dr. Richard Pazdur's 25 Year WAR on Cancer at the FDA!

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Special Coverage